Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
08/2003
08/13/2003EP1132090B1 Method for producing an agent for treating ulcers of the organism
08/13/2003EP1073658B1 Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction
08/13/2003EP0989859B1 Cns neuroregenerative compositions and methods of use
08/13/2003EP0971948B1 Inhibitors for urokinase receptor
08/13/2003EP0956287B1 3-aryl-2-(1-substituted-4-piperidinyl)-1(1-di)oxo-3h-benzo d]-isothiazole derivatives, their preparation and their use as modulators of neurotransmitter function
08/13/2003EP0946539B1 Sulphonamide derivatives, process for their preparation, and their use as medicaments
08/13/2003EP0923568B9 Novel benzofuran-4-carboxamides
08/13/2003EP0891328B1 Peptidyl compounds having mmp and tnf inhibitory activity
08/13/2003EP0879233B1 Chinoline and benzimidazole derivatives as bradykinin agonists
08/13/2003EP0814809B1 Aryl thioxanthines
08/13/2003EP0665843B1 Substituted quinuclidines as substance p antagonists
08/13/2003EP0614374B1 MURINE MONOCLONAL ANTIBODY (5c8) RECOGNIZES A HUMAN GLYCOPROTEIN ON THE SURFACE OF T-LYMPHOCYTES
08/13/2003EP0572553B1 Recombinant thrombin receptor and related pharmaceuticals
08/13/2003EP0531472B1 Humanized monoclonal antibodies
08/13/2003CN1436246A Method for preparing physiologically active IL-18 polypeptide
08/13/2003CN1436241A Sphingosine kinase and uses thereof
08/13/2003CN1436235A Anti-angiogenic polypeptides
08/13/2003CN1436197A Novel compounds of N-acylamino-amide family, compositions comprising same and uses
08/13/2003CN1436195A Integrin binding peptide derivatives
08/13/2003CN1436192A HMG-CoA reductase inhibitors and method
08/13/2003CN1436191A Heteroaryldiazabicycloalkanes as nicotinic cholinergic receptor ligands
08/13/2003CN1436189A Non-nucleoside reverse transcriptase inhibitors
08/13/2003CN1436188A 1,3,8-triaza-spiroÒÇö4,5ÒÇòdecan-4-one derivs. as neurokinin receptor antagonists
08/13/2003CN1436186A Process for preparation of sulfonamide derivs. and crystals thereof
08/13/2003CN1436185A Thrombin receptor antagonists
08/13/2003CN1436180A Diamino phenothiazine derivs. and composition comprising same
08/13/2003CN1436175A Cyclic lactams as inhibitors of A beta-protein production
08/13/2003CN1436174A HMG-CoA reductase inhibitors and their use as medicaments for treatment of cholesterol related diseases
08/13/2003CN1436172A 1,2-dihydropyridine compounds, process for preparation of same and use thereof
08/13/2003CN1436086A Interferon for treatment of multiple sclerosis
08/13/2003CN1436080A Use of cyclic-GMP-specific phosphodiesterase inhibitor for treating parkinson's disease
08/13/2003CN1436074A Remedies
08/13/2003CN1435257A Epidermal mucosa disinfectant contg. recombinant human epidermal growth factor
08/13/2003CN1435234A Tonic liquid and preparing process thereof
08/13/2003CN1435229A ÔÇ£ErbeimuÔÇØ capsule preparing process thereof
08/13/2003CN1435215A Zaizao Pill for treating woman diseases
08/13/2003CN1435214A Compound body-strengthening eucommia bark mixture for treating diseases caused by kidney Qi deficiency
08/13/2003CN1435197A Chinese medicine formulation of ant tonic medicinal liquor and preparing method thereof
08/13/2003CN1435187A Neural stem cell preparation, preparing method thereof and use of same
08/13/2003CN1435185A Cell growth regulatory factor A and preparing process thereof
08/13/2003CN1435184A Cell growth regulatory factor C and preparing process thereof
08/13/2003CN1435183A Cell growth regulatory factor L and preparing process thereof
08/13/2003CN1435182A Cell growth regulatory factor N and preparing process thereof
08/13/2003CN1435179A Biologic converted ginseng composition and preparing process thereof
08/13/2003CN1117759C Steroid, its preparation method, medicine composition and use thereof
08/13/2003CN1117755C Spiroazabicyclic heterocyclic compounds, method for preparing same and use thereof
08/13/2003CN1117746C Method for preparing substd. pyridines and pyridines obtained thereby
08/13/2003CN1117745C Noval tricyclic N-cyanoimines useful as inhibitors of farnesyl-protein transferase
08/13/2003CN1117744C 1-(1,2-disubstd. piperidinyl)-4-substd. piperazine derivs.
08/13/2003CN1117738C Endothelin antagonists
08/13/2003CN1117579C Plaster for treating common cold
08/13/2003CN1117571C Improved calcium dietary supplement
08/13/2003CN1117569C Bicyclic fibrinogen antagonists
08/13/2003CN1117568C Gastrokinetic bicyclie benzamides of 3-or 4-substd. 4-(aminomethyl)-piperidine derivs.
08/13/2003CN1117566C Combination therapy comprising amlodipine and statin compound
08/13/2003CN1117564C Use of prumipexole in treating of restless legs syndrome
08/12/2003US6605753 Transgenic mouse with increased insulin sensitivity; resistance to weight gain when fed a high fat, high carbohydrate diet
08/12/2003US6605725 Treating a central or peripheral nervous system disorder or condition through modulation of a voltage-dependent potassium channel
08/12/2003US6605723 Process for the preparation of ethanesul fonyl-piperidine derivatives
08/12/2003US6605722 Tyrosine derivatives with anti-leukotrienen activity
08/12/2003US6605642 Inhibitors of formation of advanced glycation endproducts (AGES)
08/12/2003US6605640 Treating a retinal or choroidal vascular or hereditary disease by topically administering an acetylcholine esterase inhibitor, e.g., Phospholine Iodide; age related macular degeneration disease; diabetic retinopathy
08/12/2003US6605637 Lipoic acid derivatives, their preparation, and pharmaceutical compositions containing them
08/12/2003US6605636 Atorvastatin hemi-calcium form VII
08/12/2003US6605633 Such as 5-Bromo-2-phenyl-1H-indole-3-butanoic acid
08/12/2003US6605632 Affinity for melatonin receptors
08/12/2003US6605629 Oxazole derivatives; low toxicity
08/12/2003US6605625 Antiarrhythmia agents
08/12/2003US6605621 Monomeric and dimeric heterocycles, and therapeutic uses thereof
08/12/2003US6605617 Treating a patient in need of an inhibitor of vascular endothelial growth factor receptor tyrosine kinase
08/12/2003US6605612 Cardioprotective phosohonates and malonates
08/12/2003US6605610 Aryl fused azapolycyclic compounds
08/12/2003US6605607 Antihypertensives; hyperprolactinaemia related conditions; certain central nervous system disorders
08/12/2003US6605604 Carboxylic and hydroxamic acid compounds inhibiting metalloproteases, method for preparing same and pharmaceutical compositions containing them
08/12/2003US6605603 Uses of 1-amino-3-(N,N-dimethylamino)-propylidene-1,1-bisphosphonic acid
08/12/2003US6605600 Diuretics
08/12/2003US6605599 Epothilone derivatives
08/12/2003US6605597 Partial or full A1agonists-N-6 heterocyclic 5′-thio substituted adenosine derivatives
08/12/2003US6605596 Indolocarbazole anticancer agents and methods of using them
08/12/2003US6605591 Treatment of subnormal bone mineral density
08/12/2003US6605456 Nucleic acids encoding IKR-2, a protein kinase related to the I kappa B kinases
08/12/2003US6605443 Drug screening for compound which disrupts Smad7 transforming growth-beta factor superfamily signal transduction inhibitory activity
08/12/2003US6605426 Compounds, methods of screening, and in vitro and in vivo uses involving anti-apoptotic genes and anti-apoptotic gene products
08/12/2003US6605286 Delivery of biologically active polypeptides
08/12/2003US6605280 Interleukin-18 binding proteins, their preparation and use for blocking the activity of IL-18
08/12/2003US6605276 Treatment of ulcerative colitis with tropomyosin isoforms and monoclonal antibodies to tropomyosin isoforms
08/12/2003US6605115 Method and composition for inhibiting cardiovascular cell proliferation
08/12/2003CA2212836C Substituted isoxazoles for the treatment of inflammation
08/12/2003CA2116888C Human anti-tnf antibodies
08/12/2003CA2088702C Aminobenzoic acid derivatives
08/08/2003WO2002060922A2 Epoxyvibsanin b
08/08/2003CA2458220A1 Epoxyvibsanin b
08/07/2003WO2003065046A2 Diagnostics and therapeutics for diseases associated with a new human 5-ht6 receptor
08/07/2003WO2003064663A1 Polymorphisms in elastin, fibrillin, and related genes as predisposing to restenosis and to atherosclerosis
08/07/2003WO2003064647A1 Method of controlling circadian rhythm
08/07/2003WO2003064632A1 Methods for inducing the differentiation of monocytes into functional dendritic cells and immunotherapeutic compositions including such dendritic cells
08/07/2003WO2003064629A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/07/2003WO2003064626A2 Double-stranded oligonucleotides
08/07/2003WO2003064625A2 Oligonucleotide compositions with enhanced efficiency
08/07/2003WO2003064622A2 Aggrecanase molecules
1 ... 740 741 742 743 744 745 746 747 748 749 750 751 752 753 754 755 756 757 758 759 760 ... 1564